- Stocks
- Pharma & Healthcare
- Sanofi Consumer Healthcare India
Sanofi Consumer Healthcare India share price
NSE: SANOFICONRPharma & HealthcareDrug Manufacturers - General
Sanofi Consumer Healthcare India at a glance
Sanofi Consumer Healthcare India (NSE: SANOFICONR) closed at ₹3,473.40 on 19 Oct 2026, down 2.39% on the day. With a market capitalisation of ₹7,999 Cr, it ranks 628th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - General.
At its last close the stock traded at 31× trailing earnings, against a return on equity of 62.5% in FY26. Over the past year the share price has fallen 25.8%. Its 52-week range is ₹3,455.80 (19 Oct 2026) to ₹5,255.00 (14 May 2026); the last close is 33.9% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹236 Cr (+6.7% year on year) and net profit ₹69 Cr (+13.3%), on a standalone basis. Promoters held 71.27% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹7,999 CrRank 628 on NSE
- P/E (trailing)
- 31×
- Price to book
- 27.11×FY26
- EPS (TTM)
- ₹115.49to Q1 FY27
- ROE
- 62.5%FY26
- ROCE
- 75.4%FY26
- Debt to equity
- 0FY26
- Net profit margin
- 27.3%FY26
- Book value / share
- ₹166.96FY26
- 52-week high
- ₹5,255.0014 May 2026
- 52-week low
- ₹3,455.8019 Oct 2026
- 1-year return
- −25.8%
- RSI (14-day)
- 23
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | −2.39% | −2.9% | −13.7% | −23.2% | −25.8% |
Sanofi Consumer Healthcare India quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹160 Cr | ₹171 Cr | ₹173 Cr | ₹221 Cr | ₹234 Cr | ₹251 Cr | ₹229 Cr | ₹236 Cr |
| Revenue YoY | −24.0% | −24.0% | −18.3% | +34.4% | +46.3% | +47.0% | +32.8% | +6.7% |
| Net profit | ₹45 Cr | ₹44 Cr | ₹50 Cr | ₹61 Cr | ₹63 Cr | ₹67 Cr | ₹68 Cr | ₹69 Cr |
| Net profit YoY | −36.8% | −34.8% | −20.3% | +109.3% | +39.8% | +50.1% | +35.6% | +13.3% |
| Net margin | 28.1% | 26.0% | 29.0% | 27.5% | 26.9% | 26.5% | 29.6% | 29.2% |
| EPS | ₹19.54 | ₹19.25 | ₹21.69 | ₹26.36 | ₹27.31 | ₹28.87 | ₹29.44 | ₹29.87 |
Sanofi Consumer Healthcare India financials
| Item | FY23 | FY24 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹555 Cr | ₹0 Cr | ₹725 Cr | ₹878 Cr |
| Operating profit | −₹0 Cr | ₹221 Cr | ₹0 Cr | ₹275 Cr | ₹314 Cr |
| Net profit | −₹0 Cr | ₹165 Cr | ₹0 Cr | ₹181 Cr | ₹240 Cr |
| EPS (₹) | −₹1.51 | ₹71.60 | ₹0.00 | ₹78.59 | ₹104.27 |
| Cash from operations | −₹0 Cr | −₹0 Cr | −₹0 Cr | ₹439 Cr | ₹175 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹2 Cr | ₹208 Cr | ₹2 Cr | ₹273 Cr | ₹384 Cr |
Sanofi Consumer Healthcare India shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 60.40% | 71.27% | 71.27% | 71.27% | 71.27% | 71.27% |
| Foreign institutions | 4.53% | 3.24% | 2.94% | 2.83% | 2.76% | 2.60% |
| Domestic institutions | 25.48% | 16.89% | 17.21% | 17.33% | 17.57% | 17.86% |
| Non-institutions | 9.59% | 8.59% | 8.58% | 8.56% | 8.40% | 8.27% |
Sanofi Consumer Healthcare India vs peers
The listed Pharma & Healthcare companies nearest to Sanofi Consumer Healthcare India by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| YATHARTHYatharth Hospital & Trauma Care Services | ₹968.00 | −2.52% | +19.5% | ₹9,327 Cr | 53.1 | — |
| HCGHealthcare Global Enterprises | ₹570.00 | −3.39% | −16.4% | ₹8,510 Cr | — | — |
| SUVENSuven Life Sciences | ₹290.50 | −4.71% | +39.0% | ₹8,208 Cr | — | — |
| SANOFICONRSanofi Consumer Healthcare India | ₹3,473.40 | −2.39% | −25.8% | ₹7,999 Cr | 31 | — |
| AARTIPHARMAarti Pharmalabs | ₹835.00 | −4.78% | +0.3% | ₹7,572 Cr | 43.4 | — |
| THYROCAREThyrocare Technologies | ₹469.95 | −3.12% | +11.1% | ₹7,480 Cr | 46.1 | — |
| SUPRIYASupriya Lifescience | ₹872.50 | −1.55% | +20.7% | ₹7,022 Cr | 33.6 | — |
Ask anything about Sanofi Consumer Healthcare India
Pivot answers on the live chart with evidence you can check, and tests strategies against SANOFICONR's own history. Try: “Why has SANOFICONR moved over the last three months?” · “Backtest a 50-day moving-average crossover on SANOFICONR over five years” · “Compare SANOFICONR with YATHARTH on margins and valuation”
Frequently asked questions about Sanofi Consumer Healthcare India
What is the share price of Sanofi Consumer Healthcare India today?
Sanofi Consumer Healthcare India (NSE: SANOFICONR) last closed at ₹3,473.40 on 19 Oct 2026. Its 52-week high is ₹5,255.00 and its 52-week low is ₹3,455.80.
What is the market cap of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India's market capitalisation is ₹7,999 Cr (₹7,999 Cr) at the 19 Oct 2026 close, ranking 628th among the NSE companies Pivot tracks.
What is the P/E ratio of Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India trades at a trailing P/E of 31. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 46.1.
What is the ROE and ROCE of Sanofi Consumer Healthcare India?
Return on equity was 62.5% in FY26 and return on capital employed was 75.4% in FY26 (standalone figures).
Is Sanofi Consumer Healthcare India a debt-free company?
Sanofi Consumer Healthcare India is close to debt-free: its debt-to-equity ratio was 0 in FY26.
What were Sanofi Consumer Healthcare India's latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Sanofi Consumer Healthcare India reported revenue of ₹236 Cr, +6.7% year on year, and net profit of ₹69 Cr, +13.3% year on year.
How has Sanofi Consumer Healthcare India stock performed over the last year?
Sanofi Consumer Healthcare India's share price has fallen 25.8% over the past year, −23.2% over three months and −13.7% over one month, to the 19 Oct 2026 close.
What is the shareholding pattern of Sanofi Consumer Healthcare India?
As of 30 Jun 2026: promoters 71.27%, foreign institutions 2.60%, domestic institutions 17.86%, non-institutions 8.27%.
Who are Sanofi Consumer Healthcare India's competitors?
The listed Pharma & Healthcare companies closest to Sanofi Consumer Healthcare India by market cap are Yatharth Hospital & Trauma Care Services, Healthcare Global Enterprises, Suven Life Sciences, Aarti Pharmalabs, Thyrocare Technologies and Supriya Lifescience.
Is Sanofi Consumer Healthcare India a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Sanofi Consumer Healthcare India's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SANOFICONR against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with S · all NSE stocks · this page as text